The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota

Boursier, Jérôme, Mueller, Olaf, Barret, Matthieu, Machado, Mariana, Fizanne, Lionel, Araujo‐Perez, Felix, Guy, Cynthia D., Seed, Patrick C. +6 more·2016·Hepatology

DOI 10.1002/hep.28356

Cited by (1,000)

Items 101–200 of 1,000

Evidence‐based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
Sumio Watanabe, Etsuko Hashimoto, Kenichi Ikejima, Hirofumi Uto, Masafumi Ono, Yoshio Sumida, Masataka Seike, Yoshiyuki Takei, Tetsuo Takehara, Katsutoshi Tokushige et al. · 2015 · Hepatology Research
The Relationship between Choline Bioavailability from Diet, Intestinal Microbiota Composition, and Its Modulation of Human Diseases
Natalia Arias, Silvia Arboleya, Joseph Allison, Aleksandra Kaliszewska, Sara G. Higarza, Miguel Gueimonde, Jorge Luis Arias · 2020 · Nutrients
Integrated analysis of microbiome and host transcriptome reveals correlations between gut microbiota and clinical outcomes in HBV-related hepatocellular carcinoma
Hechen Huang, Zhigang Ren, Xingxing Gao, Xiaoyi Hu, Yuan M. Zhou, Jianwen Jiang, Haifeng Lu, Shengyong Yin, Junfang Ji, Lin Zhou et al. · 2020 · Genome Medicine
Host-microbiome interactions: Gut-Liver axis and its connection with other organs
Swadha Anand, Sharmila S. Mande · 2022 · npj Biofilms and Microbiomes
Antibiotic perturbation of the murine gut microbiome enhances the adiposity, insulin resistance, and liver disease associated with high-fat diet
Douglas Mahana, Chad M. Trent, Zachary D. Kurtz, Nicholas A. Bokulich, Thomas Battaglia, Jennifer Chung, Christian L. Müller, Huilin Li, Richard Bonneau, Martin J. Blaser · 2016 · Genome Medicine
Prolonged high-fat-diet feeding promotes non-alcoholic fatty liver disease and alters gut microbiota in mice
Kandy T. Velázquez, Reilly T. Enos, Jackie E. Bader, Alexander T. Sougiannis, Meredith S. Carson, Ioulia Chatzistamou, James A. Carson, Prakash S. Nagarkatti, Mitzi Nagarkatti, E. Angela Murphy · 2019 · World Journal of Hepatology
Intestinal Microbiota and Nonalcoholic Steatohepatitis
Brandl, Katharina, Schnabl, Bernd · 2017 · Current Opinion in Gastroenterology
Gut microbiome, endocrine control of gut barrier function and metabolic diseases
Marion Régnier, Matthias Van Hul, Claude Knauf, Patrice D. Cani · 2020 · Journal of Endocrinology
Naringin Attenuates High Fat Diet Induced Non-alcoholic Fatty Liver Disease and Gut Bacterial Dysbiosis in Mice
Hongna Mu, Qi Zhou, Ruiyue Yang, Jie Zeng, Xianghui Li, Ranran Zhang, Weiqing Tang, Hongxia Li, Siming Wang, Tao Shen et al. · 2020 · Frontiers in Microbiology
Gut Microbiota and NAFLD: Pathogenetic Mechanisms, Microbiota Signatures, and Therapeutic Interventions
Tomas Hrncir, Lucia Hrncirova, Miloslav Kverka, Róbert Hromádka, Vladimira Machova, Eva Trckova, Klara Kostovcikova, Pavlína Králíčková, Jan Krejsek, Helena Tlaskalová‐Hogenová · 2021 · Microorganisms
Recent Epidemiology and Risk Factors of Nonalcoholic Fatty Liver Disease
Youn Huh, Yoon Jeong Cho, Ga Eun Nam · 2022 · Journal of Obesity & Metabolic Syndrome
Chronic opioid use is associated with altered gut microbiota and predicts readmissions in patients with cirrhosis
Acharya, C., Betrapally, N. S., Gillevet, P. M., Sterling, R. K., Akbarali, H., White, M. B., Ganapathy, D., Fagan, A., Sikaroodi, M., Bajaj, J. S. · 2017 · Alimentary Pharmacology & Therapeutics
The acidic pathway of bile acid synthesis: Not just an alternative pathway
William M. Pandak, Genta Kakiyama · 2019 · Liver Research
Comparison of the Phenotype and Approach to Pediatric vs Adult Patients With Nonalcoholic Fatty Liver Disease
Valério Nobili, Anna Alisi, Kimberly P. Newton, Jeffrey B. Schwimmer · 2016 · Gastroenterology
The role of the gut microbiome in chronic liver disease: the clinical evidence revised
Katherine J. P. Schwenger, Nayima M. Clermont‐Dejean, Johane P. Allard · 2019 · JHEP Reports
Endotoxin Producers Overgrowing in Human Gut Microbiota as the Causative Agents for Nonalcoholic Fatty Liver Disease
Na Fei, Aurélia Bruneau, Xiaojun Zhang, Ruirui Wang, Jin‐Xing Wang, Sylvie Rabot, Philippe Gérard, Liping Zhao · 2020 · mBio
Emerging Role of the Gut Microbiome in Nonalcoholic Fatty Liver Disease: From Composition to Function
Suzanne R. Sharpton, Veeral H. Ajmera, Rohit Seth Loomba · 2018 · Clinical Gastroenterology and Hepatology
Microbiota changes and intestinal microbiota transplantation in liver diseases and cirrhosis
Jasmohan Singh Bajaj, Alexander Khoruts · 2020 · Journal of Hepatology
Role of gut microbiota via the gut-liver-brain axis in digestive diseases
Jianhong Ding, Zhe Jin, Xiaoxu Yang, Jun Lou, Weixi Shan, Yanxia Hu, Qian Du, Qiushi Liao, Rui Xie, Jingyu Xu · 2020 · World Journal of Gastroenterology
The Gut-Liver Axis in Health and Disease: The Role of Gut Microbiota-Derived Signals in Liver Injury and Regeneration
Zhipeng Zheng, Baohong Wang · 2021 · Frontiers in Immunology
Faecal microbiota from patients with cirrhosis has a low capacity to ferment non‐digestible carbohydrates into short‐chain fatty acids
Mingliang Jin, Sylvia Kalainy, Nami Baskota, Diana Chiang, Edward C. Deehan, Chelsea McDougall, Puneeta Tandon, Inés Martínez, Carlos Cervera, Jens Walter et al. · 2019 · Liver International
Intestinal permeability in the pathogenesis of liver damage: From non-alcoholic fatty liver disease to liver transplantation
Alberto Nicoletti, Francesca Romana Ponziani, Marco Biolato, Venanzio Valenza, Giuseppe Marrone, Gabriele Sganga, Antonio Gasbarrini, Luca Miele, Antonio Grieco · 2019 · World Journal of Gastroenterology
Liver Steatosis, Gut-Liver Axis, Microbiome and Environmental Factors. A Never-Ending Bidirectional Cross-Talk
Agostino Di Ciaula, Jacek Baj, Gabriella Garruti, Giuseppe Celano, Maria De Angelis, Helen H. Wang, Domenica Maria Di Palo, Leonilde Bonfrate, David Q.‐H. Wang, Piero Portincasa · 2020 · Journal of Clinical Medicine
The interaction between the gut Microbiota and herbal medicines
Xuedong An, Qi De Bao, Sha Di, Yiru Chen Zhao, Shenghui Zhao, Haiyu Zhang, Fengmei Lian, Xiaolin Tong · 2019 · Biomedicine & Pharmacotherapy
Periodontitis, chronic liver diseases, and the emerging oral‐gut‐liver axis
Emmanuel Albuquerque‐Souza, Sinem E. Sahingur · 2022 · Periodontology 2000
Altered Microbiome in Patients With Cirrhosis and Complications
Chathur Acharya, Jasmohan Singh Bajaj · 2018 · Clinical Gastroenterology and Hepatology
Donor Fecal Microbiota Transplantation Alters Gut Microbiota and Metabolites in Obese Individuals With Steatohepatitis
Julia J. Witjes, Loek P. Smits, Ceyda Tuğba Pekmez, Andrei Prodan, Abraham Stijn Meijnikman, Marian Troelstra, Kristien E. C. Bouter, Hilde Herrema, Evgeni Levin, Adriaan Georgius Holleboom et al. · 2020 · Hepatology Communications
Non-alcoholic Fatty Liver Disease: A Clinical Update
Joseph M Pappachan, S. Vinod Babu, Babu Krishnan, Nishal Ravindran · 2017 · Journal of Clinical and Translational Hepatology
Antibodies Set Boundaries Limiting Microbial Metabolite Penetration and the Resultant Mammalian Host Response
Uchimura, Yasuhiro, Fuhrer, Tobias, Li, Hai, Lawson, Melissa A., Zimmermann, Michael, Yilmaz, Bahtiyar, Zindel, Joel, Ronchi, Francesca, Sorribas, Marcel, Hapfelmeier, Siegfried et al. · 2018 · Immunity
Role of gut microbiota in liver disease
Somaya A. M. Albhaisi, Jasmohan Singh Bajaj, Arun Jayant Sanyal · 2019 · American Journal of Physiology-Gastrointestinal and Liver Physiology
Role of Gut Dysbiosis in Liver Diseases: What Have We Learned So Far?
Hiroshi Fukui · 2019 · Diseases
Liver–Microbiome Axis in Health and Disease
Timon Erik Adolph, Christoph Grander, Alexander Rupert Moschen, Herbert Tilg · 2018 · Trends in Immunology
Interaction of gut microbiota with dysregulation of bile acids in the pathogenesis of nonalcoholic fatty liver disease and potential therapeutic implications of probiotics
Jiezhong Chen, Michael Thomsen, Luis Vitetta · 2018 · Journal of Cellular Biochemistry
Bile acids profile, histopathological indices and genetic variants for non-alcoholic fatty liver disease progression
Nisreen A. Nimer, Ibrahim Choucair, Zeneng Wang, Ina Nemet, Lin Li, Janet Gukasyan, Taylor L. Weeks, Naim Alkhouri, Nizar N. Zein, W.H. Wilson Tang et al. · 2020 · Metabolism
Indole Alleviates Diet‐Induced Hepatic Steatosis and Inflammation in a Manner Involving Myeloid Cell 6‐Phosphofructo‐2‐Kinase/Fructose‐2,6‐Biphosphatase 3
Linqiang Ma, Honggui Li, Jinbo Hu, Juan Zheng, Jing Zhou, Rachel E. Botchlett, Destiny Matthews, Tianshu Zeng, Lulu Chen, Xiaoqiu Xiao et al. · 2020 · Hepatology
Prebiotic and probiotic treatment of nonalcoholic fatty liver disease: a systematic review and meta-analysis
Brett R. Loman, Diego Hernández‐Saavedra, Ruopeng An, R. Scott Rector · 2018 · Nutrition Reviews
Activation of a Specific Gut Bacteroides-Folate-Liver Axis Benefits for the Alleviation of Nonalcoholic Hepatic Steatosis
Shanshan Qiao, Bao Li, Kai Wang, Shanshan Sun, Mingfang Liao, Chang Liu, Nan Zhou, Ke Ma, Yuwei Zhang, Yihua Chen et al. · 2020 · Cell Reports
Extracellular Vesicles in Metabolic Syndrome
Maria Carmen Martínez, Ramaroson Andriantsitohaina · 2017 · Circulation Research
The Role of Gut–Liver Axis in Gut Microbiome Dysbiosis Associated NAFLD and NAFLD-HCC
Qian Song, Xiang Zhang · 2022 · Biomedicines
Peroxisome Proliferator-Activated Receptors and Their Novel Ligands as Candidates for the Treatment of Non-Alcoholic Fatty Liver Disease
Anne Fougerat, Alexandra Montagner, Nicolas Loiseau, Hervé Guillou, Walter Wahli · 2020 · Cells
Non-alcoholic fatty liver disease in adults: clinic, diagnostics, treatment. Guidelines for therapists, third version
Leonid Borisovich Lazebnik, Е. В. Голованова, Светлана Владимировна Туркина, K. L. Raikhelson, S. V. Okovityy, Oksana M. Drapkina, Igor Veniaminovich Maev, Martynov Ai, Г. Е. Ройтберг, Olga V. Khlynova et al. · 2021 · Экспериментальная и клиническая гастроэнтерология
The metabolic role of the gut microbiota in health and rheumatic disease: mechanisms and interventions
Shahla Abdollahi‐Roodsaz, Steven B. Abramson, José U. Scher · 2016 · Nature Reviews Rheumatology
The Role of Probiotics in Nonalcoholic Fatty Liver Disease: A New Insight into Therapeutic Strategies
Marica Meroni, Miriam Longo, Paola Dongiovanni · 2019 · Nutrients
Evidence‐based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020
Katsutoshi Tokushige, Kenichi Ikejima, Masafumi Ono, Yuichiro Eguchi, Yoshihiro Kamada, Yoshito Itoh, Norio Akuta, Masato Yoneda, Motoh Iwasa, Masashi Yoneda et al. · 2021 · Hepatology Research
Contribution of the gut microbiota to the regulation of host metabolism and energy balance: a focus on the gut–liver axis
Nathalie M. Delzenne, Christelle Knudsen, Martín Beaumont, Julie Rodriguez, Audrey M. Neyrinck, Laure B. Bindels · 2019 · Proceedings of The Nutrition Society
NAFLD and Extra-Hepatic Comorbidities: Current Evidence on a Multi-Organ Metabolic Syndrome
Valerio Rosato, Mario Masarone, Marcello Dallio, Alessandro Federico, Andrea Aglitti, Marcello Persico · 2019 · International Journal of Environmental Research and Public Health
Iron status influences non-alcoholic fatty liver disease in obesity through the gut microbiome
Jordi Mayneris‐Perxachs, Marina Cardellini, Lesley Hoyles, Jèssica Latorre, Francesca Davato, José María Moreno‐Navarrete, María Arnoriaga‐Rodríguez, Matteo Sérino, James Abbott, Richard H. Barton et al. · 2021 · Microbiome
Metagenomic insights into the structure and function of intestinal microbiota of the farmed Pacific white shrimp (Litopenaeus vannamei)
Shuo Gao, Luqing Pan, Fei Huang, Mengsi Song, Changcheng Tian, Mengyu Zhang · 2018 · Aquaculture
Current status, problems, and perspectives of non-alcoholic fatty liver disease research
Naoki Tanaka, Takefumi Kimura, Naoyuki Fujimori, Tadanobu Nagaya, Michiharu Komatsu, Eiji Tanaka · 2019 · World Journal of Gastroenterology
Gut microbiome composition in lean patients with NASH is associated with liver damage independent of caloric intake: A prospective pilot study
Sebastião Mauro Bezerra Duarte, José Tadeu Stefano, Luca Miele, Francesca Romana Ponziani, Marcela de Souza-Basqueira, L.S.R.R. Okada, Fernando Costa, K. Toda, Daniel Ferraz de Campos Mazo, Éster Cerdeira Sabino et al. · 2017 · Nutrition Metabolism and Cardiovascular Diseases
The Epidemiology, Risk Profiling and Diagnostic Challenges of Nonalcoholic Fatty Liver Disease
Umair Iqbal, Brandon J. Perumpail, Daud H. Akhtar, Donghee Kim, Aijaz Ahmed · 2019 · Medicines
Diets Alter the Gut Microbiome of Crocodile Lizards
Haiying Jiang, Jinge Ma, Juan Li, Xiujuan Zhang, Linmiao Li, Nan He, Hai-Yang Liu, Shuyi Luo, Zhengjun Wu, Ri-Chou Han et al. · 2017 · Frontiers in Microbiology
Pathogenesis of NASH: the Impact of Multiple Pathways
Mazen Noureddin, Arun Jayant Sanyal · 2018 · Current Hepatology Reports
The microbiome and hepatobiliary-pancreatic cancers
Kosuke Mima, Shigeki Nakagawa, Hiroshi Sawayama, Takatsugu Ishimoto, Katsunori Imai, Masaaki Iwatsuki, Daisuke Hashimoto, Yoshifumi Baba, Yo‐ichi Yamashita, Naoya Yoshida et al. · 2017 · Cancer Letters
Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease
Ki Tae Suk, Dong Joon Kim · 2019 · Expert Review of Gastroenterology & Hepatology
Metabolic causes and consequences of nonalcoholic fatty liver disease (NAFLD)
Paria Zarghamravanbakhsh, Michael Frenkel, Leonid Poretsky · 2021 · Metabolism Open
Marine polysaccharides attenuate metabolic syndrome by fermentation products and altering gut microbiota: An overview
Xueliang Wang, Xin Wang, Hao Jiang, Chao Cai, Guoyun Li, Jiejie Hao, Guangli Yu · 2018 · Carbohydrate Polymers
Serum bile acid patterns are associated with the presence of NAFLD in twins, and dose‐dependent changes with increase in fibrosis stage in patients with biopsy‐proven NAFLD
Cyrielle Caussy, Cynthia L. Hsu, Seema Singh, Shirin Bassirian, James Kolar, Claire Faulkner, Nikhil Sinha, Ricki Bettencourt, Naveen Gara, Mark A. Valasek et al. · 2018 · Alimentary Pharmacology & Therapeutics
Triangulating nutrigenomics, metabolomics and microbiomics toward personalized nutrition and healthy living
Lagoumintzis, George, Patrinos, George P. · 2023 · Human Genomics
Gut–X axis
Lin Xu, Yu Zhang, Xueyan Li, Changzhou Li, Hui Hu, Jiachun Hu, Mian Liu, Qin Zhao Yang, Peng Gu, Jiaxin Li et al. · 2025 · iMeta
TMAVA, a Metabolite of Intestinal Microbes, Is Increased in Plasma From Patients With Liver Steatosis, Inhibits γ-Butyrobetaine Hydroxylase, and Exacerbates Fatty Liver in Mice
Mingming Zhao, Lin Zhao, Xuelian Xiong, Yuan Ming He, Wei Huang, Zihao Liu, Ji Liang, Bing Pan, Xuefeng Guo, Leibo Wang et al. · 2020 · Gastroenterology
Intestinal dysbiosis in nonalcoholic fatty liver disease (NAFLD): focusing on the gut–liver axis
Hui Ling Han, Yi Jiang, Mengyu Wang, Mebratu Melaku, Lei Liu, Yong Mei Zhao, Nadia Everaert, Bao Yi, Hongfu Zhang · 2021 · Critical Reviews in Food Science and Nutrition
A randomized controlled trial for response of microbiome network to exercise and diet intervention in patients with nonalcoholic fatty liver disease
Runtan Cheng, Lu Wang, Shenglong Le, Yifan Yang, Can Zhao, Xiangqi Zhang, Xin Yang, Ting Xu, Leiting Xu, Petri Wiklund et al. · 2022 · Nature Communications
Towards a standard diet-induced and biopsy-confirmed mouse model of non-alcoholic steatohepatitis: Impact of dietary fat source
Boland, Michelle L, Oró, Denise, Tølbøl, Kirstine S, Thrane, Sebastian T, Nielsen, Jens Christian, Cohen, Taylor S, Tabor, David E, Fernandes, Fiona, Tovchigrechko, Andrey, Veidal, Sanne S et al. · 2019 · World Journal of Gastroenterology
The circulating microbiome signature and inferred functional metagenomics in alcoholic hepatitis
Puneet Puri, Suthat Liangpunsakul, Jeffrey E. Christensen, Vijay H. Shah, Patrick S. Kamath, Gregory James Gores, Susan Walker, Megan Comerford, Barry P. Katz, Andrew J. Borst et al. · 2017 · Hepatology
The Molecular and Mechanistic Insights Based on Gut–Liver Axis: Nutritional Target for Non-Alcoholic Fatty Liver Disease (NAFLD) Improvement
Yun Seong Ji, Yue Yin, Lijun Sun, Weizhen Zhang · 2020 · International Journal of Molecular Sciences
Altered Microbiota Diversity and Bile Acid Signaling in Cirrhotic and Noncirrhotic NASH-HCC
Sydor, Svenja, Best, Jan, Messerschmidt, Insa, Manka, Paul, Vilchez-Vargas, Ramiro, Brodesser, Susanne, Lucas, Christina, Wegehaupt, Annemarie, Wenning, Chiara, Aßmuth, Sophia et al. · 2020 · Clinical and Translational Gastroenterology
Interactions between gut microbiota and non-alcoholic liver disease: The role of microbiota-derived metabolites
Yufang Ding, Karin Yanagi, Clint Cheng, Robert Christopher Alaniz, Kyongbum Lee, Arul Jayaraman · 2019 · Pharmacological Research
The Role of the Gut-Liver Axis in Metabolic Dysfunction-Associated Fatty Liver Disease
Rosa Martín‐Mateos, Agustı́n Albillos · 2021 · Frontiers in Immunology
α-D-1,3-glucan from Radix Puerariae thomsonii improves NAFLD by regulating the intestinal flora and metabolites
Qiong Li, Wenjun Liu, Hua Zhang, Chong Chen, Ronghua Liu, Hengwei Hou, Quan Luo, Qinqin Yu, Hui Ouyang, Yulin Feng et al. · 2022 · Carbohydrate Polymers
Diet, Microbiota, Obesity, and NAFLD: A Dangerous Quartet
Mariana Verdelho Machado, Helena Cortez‐Pinto · 2016 · International Journal of Molecular Sciences
Nonalcoholic Fatty Liver Disease in Children: Unique Considerations and Challenges
Dana L. Goldner, Joel E. Lavine · 2020 · Gastroenterology
Understanding the Effects of Gut Microbiota Dysbiosis on Nonalcoholic Fatty Liver Disease and the Possible Probiotics Role: Recent Updates
Ashiq Khan, Zitong Ding, Muhammad Hamza Ishaq, Ali Sher Bacha, ISRAR AHMAD KHAN, Anum Hanif, Wenyuan Li, Xusheng Guo · 2021 · International Journal of Biological Sciences
Limosilactobacillus reuteri in Health and Disease
Jumana Abuqwider, Mohammad Altamimi, Gianluigi Mauriello · 2022 · Microorganisms
Yogurt improves insulin resistance and liver fat in obese women with nonalcoholic fatty liver disease and metabolic syndrome: a randomized controlled trial
Yang Chen, Rennan Feng, Xue Qin Yang, Jiaxing Dai, Min Huang, Xiaoning Ji, Yong Li, Akinkunmi Paul Okekunle, Guanghui Gao, Justina Ucheojor Onwuka et al. · 2019 · American Journal of Clinical Nutrition
Theabrownin inhibits obesity and non-alcoholic fatty liver disease in mice via serotonin-related signaling pathways and gut-liver axis
Hangyu Li, Siyu Huang, Dan-Dan Zhou, Ruo-Gu Xiong, Min Luo, Adila Saimaiti, Mu-Ke Han, Ren‐You Gan, Huilian Zhu, Hua‐Bin Li · 2023 · Journal of Advanced Research
A story of liver and gut microbes: how does the intestinal flora affect liver disease? A review of the literature
Mauro Giuffrè, Michele Campigotto, Giuseppina Campisciano, Manola Comar, Lory Saveria Crocè · 2020 · American Journal of Physiology-Gastrointestinal and Liver Physiology
The interplay between dietary fatty acids and gut microbiota influences host metabolism and hepatic steatosis
Marc Schoeler, Sandrine Ellero‐Simatos, Till Birkner, Jordi Mayneris‐Perxachs, Lisa M. Olsson, Harald Brolin, Ulrike Löber, Jamie Dale Kraft, Arnaud Polizzi, Marian Martí-Navas et al. · 2023 · Nature Communications
Influence of gut microbiota on the development and progression of nonalcoholic steatohepatitis
Fabiana de Faria Ghetti, Daiane Gonçalves de Oliveira, Juliano Machado de Oliveira, Lincoln Eduardo Villela Vieira de Castro Ferreira, Dionéia Evangelista Cesar, Ana Paula Boroni Moreira · 2017 · European Journal of Nutrition
Targeting the gut microbiota with resveratrol: a demonstration of novel evidence for the management of hepatic steatosis
Pan Wang, Jing Wang, Daotong Li, Weixin Ke, Fang Chen, Xiaosong Hu · 2020 · The Journal of Nutritional Biochemistry
Compositional alterations of gut microbiota in nonalcoholic fatty liver disease patients: a systematic review and Meta-analysis
Fuxi Li, Junzhao Ye, Congxiang Shao, Bihui Zhong · 2021 · Lipids in Health and Disease
Changes in the Intestinal Microbiome and Alcoholic and Nonalcoholic Liver Diseases: Causes or Effects?
Betrapally, Naga S., Gillevet, Patrick M., Bajaj, Jasmohan S. · 2016 · Gastroenterology
Gut Microbiota’s Relationship with Liver Disease and Role in Hepatoprotection by Dietary Natural Products and Probiotics
Xiao Meng, Sha Li, Ya Li, Ren‐You Gan, Hua‐Bin Li · 2018 · Nutrients
The ecology of human microbiota: dynamics and diversity in health and disease
Antti Karkman, Jenni Lehtimäki, Lasse Ruokolainen · 2017 · Annals of the New York Academy of Sciences
Ability of prebiotic polysaccharides to activate a HIF1α-antimicrobial peptide axis determines liver injury risk in zebrafish
Zhen Zhang, Chao Ran, Qianwen Ding, Hong-liang Liu, Mingxu Xie, Yalin Yang, Ya-dong Xie, Chenchen Gao, Hongling Zhang, Zhigang Zhou · 2019 · Communications Biology
Microbial balance in the intestinal microbiota and its association with diabetes, obesity and allergic disease
Pourya Gholizadeh, Majid Mahallei, Ali Pormohammad, Mojtaba Varshochi, Khudaverdi Ganbarov, Elham Zeinalzadeh, Bahman Yousefi, Milad Bastami, Asghar Tanomand, Suhad Saad Mahmood et al. · 2018 · Microbial Pathogenesis
Caffeic acid prevents non-alcoholic fatty liver disease induced by a high-fat diet through gut microbiota modulation in mice
Hongna Mu, Qi Zhou, Ruiyue Yang, Weiqing Tang, Hong-Xia Li, Siming Wang, Jian Li, Wenxiang Chen, Jun Dong · 2021 · Food Research International
Carbohydrates great and small, from dietary fiber to sialic acids: How glycans influence the gut microbiome and affect human health
Joanna K. C. Coker, Oriane Moyne, Dmitry A. Rodionov, Karsten Zengler · 2021 · Gut Microbes
Role of Microbiota-Derived Metabolites in Alcoholic and Non-Alcoholic Fatty Liver Diseases
Ji Won Park, Sung Eun Kim, Na Young Lee, Jung Hee Kim, Jang-Han Jung, Myoung-Kuk Jang, Sang-Hoon Park, Myung-Seok Lee, Dong-Joon Kim, Hyoung-Su Kim et al. · 2021 · International Journal of Molecular Sciences
The role of gut microbiota in non-alcoholic fatty liver disease: pathways of mechanisms
Chyntia Olivia Maurine Jasirwan, Cosmas Rinaldi Adithya Lesmana, Irsan Hasan, Andri Sanityoso Sulaiman, Rino Alvani Gani · 2019 · Bioscience of Microbiota Food and Health
Cognitive Dysfunction in Non-Alcoholic Fatty Liver Disease—Current Knowledge, Mechanisms and Perspectives
Kristoffer Kjærgaard, Anne Catrine Daugaard Mikkelsen, Charlotte Wilhelmina Wernberg, Lea Ladegaard Grønkjær, Peter Lykke Eriksen, Malene Flensborg Damholdt, Rajeshwar P. Mookerjee, Hendrik Vilstrup, Mette Munk Lauridsen, Karen Louise Thomsen · 2021 · Journal of Clinical Medicine
Bifidobacteria and lactobacilli in the gut microbiome of children with non-alcoholic fatty liver disease: which strains act as health players?
Valério Nobili, Lorenza Putignani, Antonella Mosca, Federica DEL CHIERICO, Pamela Vernocchi, Anna Alisi, Laura Stronati, Salvatore Cucchiara, Marco Toscano, Lorenzo Drago · 2016 · Archives of Medical Science
Diet, Gut Microbiota and Non-Alcoholic Fatty Liver Disease: Three Parts of the Same Axis
Sergio Quesada‐Vázquez, Gerard Aragonès, Josep M Del Bas-Prior, Xavier Escoté · 2020 · Cells
Early prediction of incident liver disease using conventional risk factors and gut-microbiome-augmented gradient boosting
Yang Liu, Guillaume Méric, Aki Samuli Havulinna, Shu Mei Teo, Fredrik O. Åberg, Matti O. Ruuskanen, Jon G. Sanders, Qiyun Zhu, Anupriya Tripathi, Karin M. Verspoor et al. · 2022 · Cell Metabolism
Lacticaseibacillus rhamnosus Fmb14 prevents purine induced hyperuricemia and alleviate renal fibrosis through gut-kidney axis
Hongyuan Zhao, Xiaoyu Chen, Li Zhang, Fanqiang Meng, Libang Zhou, Xinyi Pang, Zhaoxin Lu, Yingjian Lu · 2022 · Pharmacological Research
Gut microbiota as important modulator of metabolism in health and disease
Xiang‐qian Wang, Aihua Zhang, Jian-hua Miao, Hui Juan Sun, Guangli Yan, Fangfang Wu, Xi-jun Wang · 2018 · RSC Advances
Metformin attenuates the onset of non-alcoholic fatty liver disease and affects intestinal microbiota and barrier in small intestine
Annette Brandt, Angélica María Hernández-Arriaga, Richard Kehm, Víctor Sánchez, Cheng Jun Jin, Anika Nier, Anja Baumann, Amélia Camarinha‐Silva, Ina Bergheim · 2019 · Scientific Reports
Gut microbiome and liver disease
Naga S. Betrapally, Patrick Martin Gillevet, Jasmohan Singh Bajaj · 2016 · Translational research
The nursing home elder microbiome stability and associations with age, frailty, nutrition and physical location
Haran, John P., Bucci, Vanni, Dutta, Protiva, Ward, Doyle, McCormick, Beth · 2018 · Journal of Medical Microbiology
Australian consensus statements for the regulation, production and use of faecal microbiota transplantation in clinical practice
Craig Haifer, Colleen R. Kelly, Sudarshan Paramsothy, David N. Andresen, Lito E. Papanicolas, Genevieve L. McKew, Thomas Julius Borody, Michael A. Kamm, Samuel Paul Costello, Jane Mary Andrews et al. · 2020 · Gut